Research Analysts’ Updated EPS Estimates for March 9th (ADEA, ADUR, BETA, BNS, DG, DKS, DYN, EDIT, FM, GIII)

Research Analysts’ updated eps estimates for Monday, March 9th:

Adeia (NASDAQ:ADEA) had its buy rating reaffirmed by analysts at BWS Financial. They currently have a $30.00 target price on the stock.

Aduro Clean Technologies (NASDAQ:ADUR) had its buy rating reissued by analysts at D. Boral Capital. They currently have a $46.00 target price on the stock.

BETA Technologies (NYSE:BETA) had its buy rating reaffirmed by analysts at Needham & Company LLC. They currently have a $34.00 target price on the stock.

Bank of Nova Scotia (TSE:BNS) (NYSE:BNS) was downgraded by analysts at Canaccord Genuity Group Inc. from a buy rating to a hold rating. Canaccord Genuity Group Inc. currently has C$110.00 price target on the stock, down from their previous price target of C$118.00.

Dollar General (NYSE:DG) had its market perform rating reaffirmed by analysts at Telsey Advisory Group. They currently have a $130.00 price target on the stock.

DICK’S Sporting Goods (NYSE:DKS) had its outperform rating reissued by analysts at Telsey Advisory Group. The firm currently has a $245.00 target price on the stock.

Dyne Therapeutics (NASDAQ:DYN) had its buy rating reaffirmed by analysts at Chardan Capital. Chardan Capital currently has a $38.00 target price on the stock.

Editas Medicine (NASDAQ:EDIT) had its buy rating reiterated by analysts at Chardan Capital. The firm currently has a $3.50 target price on the stock.

First Quantum Minerals (TSE:FM) was downgraded by analysts at JPMorgan Chase & Co. from an overweight rating to an underperform rating. JPMorgan Chase & Co. currently has C$28.00 target price on the stock, down from their previous target price of C$48.00.

G-III Apparel Group (NASDAQ:GIII) had its market perform rating reissued by analysts at Telsey Advisory Group. The firm currently has a $34.00 price target on the stock.

Heartflow (NASDAQ:HTFL) had its buy rating reiterated by analysts at Canaccord Genuity Group Inc.. The firm currently has a $40.00 target price on the stock.

ImmunityBio (NASDAQ:IBRX) had its buy rating reissued by analysts at D. Boral Capital. D. Boral Capital currently has a $23.00 price target on the stock.

Lundin Mining (TSE:LUN) was downgraded by analysts at JPMorgan Chase & Co. from a neutral rating to an underweight rating. JPMorgan Chase & Co. currently has C$28.20 price target on the stock, down from their previous price target of C$32.90.

Medicus Pharma (NASDAQ:MDCX) had its buy rating reissued by analysts at D. Boral Capital. They currently have a $27.00 target price on the stock.

NeuroSense Therapeutics (NASDAQ:NRSN) had its buy rating reaffirmed by analysts at D. Boral Capital. The firm currently has a $14.00 price target on the stock.

NRx Pharmaceuticals (NASDAQ:NRXP) had its buy rating reiterated by analysts at D. Boral Capital. D. Boral Capital currently has a $34.00 target price on the stock.

OS Therapies (NYSEAMERICAN:OSTX) had its buy rating reissued by analysts at D. Boral Capital. D. Boral Capital currently has a $20.00 price target on the stock.

Standex International (NYSE:SXI) had its outperform rating reaffirmed by analysts at Barrington Research. Barrington Research currently has a $260.00 price target on the stock.

Talkspace (NASDAQ:TALK) had its hold rating reiterated by analysts at Canaccord Genuity Group Inc..

Trevi Therapeutics (NASDAQ:TRVI) had its buy rating reaffirmed by analysts at D. Boral Capital. D. Boral Capital currently has a $19.00 price target on the stock.

Westrock Coffee (NASDAQ:WEST) had its outperform rating reissued by analysts at Telsey Advisory Group. Telsey Advisory Group currently has a $7.00 target price on the stock.